Sean Sachdev
Experienced in Spinal Tumor

Dr. Sean Sachdev

Radiation Oncology
251 E Huron St Ste LC-178, Galter Pavilion, 
Chicago, IL 
Offers Telehealth
14 Years of Experience
Experienced in Spinal Tumor
251 E Huron St Ste LC-178, Galter Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sean Sachdev is a Radiation Oncologist in Chicago, Illinois. Dr. Sachdev has been practicing medicine for over 14 years and is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Glioblastoma, Prostate Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Gamma Knife Radiosurgery.

His clinical research consists of co-authoring 96 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Spinal Tumor.

Graduate Institution
Stanford University School Of Medicine, 2011
Residency
McGaw Medical Center of Northwestern University
Specialties
Radiation Oncology
Licenses
Radiology in IL
Board Certifications
American Board Of Radiology - Radiation Oncology (Certified)
Hospital Affiliations
Northwestern Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

251 E Huron St Ste LC-178, Galter Pavilion, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Temozolomide
Study Phase: Phase 2
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Active_not_recruiting
Publish Date: May 09, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
View 5 Less Clinical Trials

96 Total Publications

Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.
Journal: Research square
Published: October 03, 2025
Similar Doctors
John A. Kalapurakal
Experienced in Spinal Tumor
Dr. John A. Kalapurakal
Radiation Oncology
Experienced in Spinal Tumor
Dr. John A. Kalapurakal
Radiation Oncology
251 E Huron St Ste LC-178, Galter Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-926-2520
Experience:
37+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Kalapurakal is a Radiation Oncologist in Chicago, Illinois. Dr. Kalapurakal has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Meningioma, Nephrectomy, and Gamma Knife Radiosurgery.

Timothy L. Sita
Experienced in Spinal Tumor
Dr. Timothy L. Sita
Radiation Oncology
Experienced in Spinal Tumor
Dr. Timothy L. Sita
Radiation Oncology
251 E Huron St Ste LC-178, Galter Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-926-2520
Experience:
8+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Sita is a Radiation Oncologist in Chicago, Illinois. Dr. Sita has been practicing medicine for over 8 years and is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Brain Tumor, Ependymoma, Glioblastoma, and Glioma.

Experienced in Spinal Tumor
Dr. Maryanne H. Marymont
Radiation Oncology
Experienced in Spinal Tumor
Dr. Maryanne H. Marymont
Radiation Oncology
251 E Huron St, Galter Pavillion, 
Chicago, IL 
 (0.4 miles away)
312-926-2520
Languages Spoken:
English
See accepted insurances

Maryanne Marymont is a Radiation Oncologist in Chicago, Illinois. Dr. Marymont is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Glioma, Gliomatosis Cerebri, Meningioma, Brain Tumor, and Gamma Knife Radiosurgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sachdev's expertise for a condition
ConditionClose
    View All 15 Distinguished Conditions
    View All 9 Advanced Conditions
    View All 27 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile